Clinical Response to Osimertinib Compared to Other Tyrosine Kinase Inhibitors and Chemotherapy in Non-Small Cell Lung Cancer. Archives of Clinical and Medical Case Reports, v. 4, n. 6, p. 1108–1115, 20 Nov.2020.